Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6020455 | Journal of Neuroimmunology | 2013 | 10 Pages |
Abstract
Innate and adaptive immune responses can speed nigrostriatal neurodegeneration in Parkinson's disease (PD). We posit that GM-CSF can attenuate such responses. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxicated mice, GM-CSF given prior to MPTP protected nigral dopaminergic neurons coincident with altered microglial morphologies and regulatory T cell (Treg) induction. Adoptive transfer of GM-CSF-induced Treg to MPTP mice protected nigral neurons. Gene expression analyses revealed novel immune-based neuronal protection pathways linked to the upregulation of IL-27. The results provide evidence that GM-CSF modulation of immunity could be of clinical benefit for PD.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Lisa M. Kosloski, Elizabeth A. Kosmacek, Katherine E. Olson, R. Lee Mosley, Howard E. Gendelman,